HAVCR2 and cancer: As we did not observe TIM-3 expression on leukemic cell lines (Supplementary Figure 1A), we hypothesize that high TIM-3 levels on T cells (or other immune cells) in cancer might correlate with CEACAM1 expression on target or T cells.